Literature DB >> 16905714

Comparing the part with the whole: should overlap be ignored in public health measures?

Lillian J Hayes1, Geoffrey Berry.   

Abstract

BACKGROUND: In public health, health outcomes such as cancer incidence or mortality of subgroups are often compared with health outcomes of the whole population. Our objective was to explore the effect of overlap that occurs in such comparisons and to develop a correction factor to adjust the test statistics and confidence intervals to allow for the effect in situations where the full data are not available.
METHOD: The standard error of a difference between a statistic calculated for a subgroup and for the whole population was derived theoretically both ignoring and allowing for overlap. The ratio of these standard errors was defined as the correction factor. Cancer incidence and death data (1997-2001) for the Australian state of New South Wales (NSW) were examined to demonstrate the utility of the correction factor.
RESULTS: If the overlap is ignored, significance tests are conservative and confidence intervals too wide. In an example with an overlap of 12%, the correction factor was 1.13 and the significance level of 0.08 was corrected to 0.05 by taking the overlap into account.
CONCLUSIONS: The overlap may not be of concern if the result is significant or if the subgroup is <10% of the whole population, but if the overlap is greater than 10% it should not be ignored. The easiest way of allowing for overlap is to use a correction factor, calculated from the amount of overlap, to adjust analyses that ignore overlap.

Entities:  

Mesh:

Year:  2006        PMID: 16905714     DOI: 10.1093/pubmed/fdl038

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  6 in total

1.  Accelerometer and Survey Data on Patterns of Physical Inactivity in New York City and the United States.

Authors:  Katherine F Bartley; Donna L Eisenhower; Tiffany G Harris; Karen K Lee
Journal:  Public Health Rep       Date:  2019-04-05       Impact factor: 2.792

2.  Childhood socioeconomic status, telomere length, and susceptibility to upper respiratory infection.

Authors:  Sheldon Cohen; Denise Janicki-Deverts; Ronald B Turner; Anna L Marsland; Margaretha L Casselbrant; Ha-Sheng Li-Korotky; Elissa S Epel; William J Doyle
Journal:  Brain Behav Immun       Date:  2013-07-08       Impact factor: 7.217

3.  Primary care access for mental illness in Australia: Patterns of access to general practice from 2006 to 2016.

Authors:  Louise M Farrer; Jennie Walker; Christopher Harrison; Michelle Banfield
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

4.  Expanding COVID-19 vaccine access to underserved populations through implementation of mobile vaccination units.

Authors:  Priya Sarin Gupta; Amir M Mohareb; Christine Valdes; Christin Price; Mimi Jollife; Craig Regis; Nehal Munshi; Eddie Taborda; Miriam Lautenschlager; Anne Fox; Diane Hanscom; Gina Kruse; Regina LaRocque; Joseph Betancourt; Elsie M Taveras
Journal:  Prev Med       Date:  2022-08-25       Impact factor: 4.637

5.  Causes of death among Federal Black Lung Benefits Program beneficiaries enrolled in Medicare, 1999-2016.

Authors:  Laura Kurth; Cara Halldin; A Scott Laney; David J Blackley
Journal:  Am J Ind Med       Date:  2020-09-11       Impact factor: 3.079

6.  Drug utilization in the Maastricht Study: A comparison with nationwide data.

Authors:  Johannes T H Nielen; Johanna H M Driessen; Pieter C Dagnelie; Annelies Boonen; Bart van den Bemt; Hein A W van Onzenoort; Cees Neef; Ronald M A Henry; Andrea M Burden; Simone J S Sep; Carla J van der Kallen; Miranda T Schram; Nicolaas Schaper; Coen D A Stehouwer; Luc Smits; Frank de Vries
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.